Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.95)
# 1,564
Out of 4,876 analysts
2
Total ratings
100%
Success rate
50.45%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $8.19
Upside: +22.10%